Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and … Read more
Market Cap & Net Worth: Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Inc (NASDAQ:TNDM) has a market capitalization of $1.63 Billion ($1.63 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #5960 globally and #3429 in its home market, demonstrating a 14.51% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tandem Diabetes Care Inc's stock price $23.91 by its total outstanding shares 68325927 (68.33 Million).
Tandem Diabetes Care Inc Market Cap History: 2015 to 2026
Tandem Diabetes Care Inc's market capitalization history from 2015 to 2026. Data shows change from $8.07 Billion to $1.63 Billion (-11.11% CAGR).
Index Memberships
Tandem Diabetes Care Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.06% | #168 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #701 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.36 Trillion | 0.10% | #351 of 602 |
Weight: Tandem Diabetes Care Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Tandem Diabetes Care Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tandem Diabetes Care Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.48x
Tandem Diabetes Care Inc's market cap is 1.48 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.47 Billion | $84.25 Million | -$83.45 Million | 17.44x | N/A |
| 2017 | $161.25 Million | $107.60 Million | -$73.03 Million | 1.50x | N/A |
| 2018 | $2.59 Billion | $183.87 Million | -$122.61 Million | 14.11x | N/A |
| 2019 | $4.07 Billion | $362.31 Million | -$24.75 Million | 11.24x | N/A |
| 2020 | $6.54 Billion | $498.83 Million | -$34.38 Million | 13.11x | N/A |
| 2021 | $10.28 Billion | $702.80 Million | $15.57 Million | 14.63x | 660.70x |
| 2022 | $3.07 Billion | $801.22 Million | -$94.59 Million | 3.83x | N/A |
| 2023 | $2.02 Billion | $747.72 Million | -$222.61 Million | 2.70x | N/A |
| 2024 | $2.46 Billion | $940.20 Million | -$96.03 Million | 2.62x | N/A |
| 2025 | $1.50 Billion | $1.01 Billion | -$204.71 Million | 1.48x | N/A |
Competitor Companies of TNDM by Market Capitalization
Companies near Tandem Diabetes Care Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Tandem Diabetes Care Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Tandem Diabetes Care Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Tandem Diabetes Care Inc's market cap moved from $8.07 Billion to $ 1.63 Billion, with a yearly change of -11.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.63 Billion | +8.78% |
| 2025 | $1.50 Billion | -38.98% |
| 2024 | $2.46 Billion | +21.77% |
| 2023 | $2.02 Billion | -34.19% |
| 2022 | $3.07 Billion | -70.14% |
| 2021 | $10.28 Billion | +57.32% |
| 2020 | $6.54 Billion | +60.51% |
| 2019 | $4.07 Billion | +56.99% |
| 2018 | $2.59 Billion | +1508.90% |
| 2017 | $161.25 Million | -89.02% |
| 2016 | $1.47 Billion | -81.80% |
| 2015 | $8.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tandem Diabetes Care Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.63 Billion USD |
| MoneyControl | $1.63 Billion USD |
| MarketWatch | $1.63 Billion USD |
| marketcap.company | $1.63 Billion USD |
| Reuters | $1.63 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.